Perivascular Microglial Cells of the CNS Are Bone Marrow-Derived and Present Antigen in Vivo-Reference-Cited by-同舟云学术

Perivascular Microglial Cells of the CNS Are Bone Marrow-Derived and Present Antigen in Vivo

Published:1988-01-15 Issue:4837 Volume:239 Page:290-292
ISSN:0036-8075
Container-title:Science
language:en
Short-container-title:Science

Author:

Hickey William F.¹,Kimura Hiromitsu²

Affiliation:

1. Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104-6079.

2. Department of Surgery, University of Pennsylvania, Philadelphia, PA 19104-6079.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference35 articles.

1. BARKER, C.F., ADVANCES IN IMMUNOLOGY 25: 1 (1971).

2. BENNUN, A, THE RAPID ISOLATION OF CLONABLE ANTIGEN-SPECIFIC LYMPHOCYTE-T LINES CAPABLE OF MEDIATING AUTOIMMUNE ENCEPHALOMYELITIS, EUROPEAN JOURNAL OF IMMUNOLOGY 11: 195 (1981).

3. BERAUD, E, EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS MEDIATED BY LYMPHOCYTE-T LINES - GENOTYPE OF ANTIGEN-PRESENTING CELLS INFLUENCES IMMUNODOMINANT EPITOPE OF BASIC-PROTEIN, JOURNAL OF IMMUNOLOGY 136: 511 (1986).

4. CHOU, FCH, MODIFICATIONS OF MYELIN BASIC-PROTEIN WHICH OCCUR DURING ITS ISOLATION, JOURNAL OF NEUROCHEMISTRY 28: 1051 (1977).

5. COHEN, I.R., PROGRESS IN IMMUNOLOGY 5: 1129 (1984).

Cited by 1304 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Blood–brain borders: a proposal to address limitations of historical blood–brain barrier terminology;Fluids and Barriers of the CNS;2024-01-05

2. DENDRITIC CELLS IN GLIOBLASTOMA TREATMENT: A MODERN VIEW OF THE PROBLEM AND OWN EXPERIENCE;Experimental Oncology;2023-12-28

3. The Association between Glymphatic System and Perivascular Macrophages in Brain Waste Clearance;2023-10-09

4. Inflammatory signaling pathways in the treatment of Alzheimer's disease with inhibitors, natural products and metabolites (Review);International Journal of Molecular Medicine;2023-10-04

5. The novel small molecule TPN10518 alleviates EAE pathogenesis by inhibiting AP1 to depress Th1/Th17 cell differentiation;International Immunopharmacology;2023-10